Alnylam Pharmaceuticals-The Leading RNAi Therapeutics Company | Canada
Alnylam is leading the translation of RNA interference (RNAi) into a innovative, entirely new class of medicines which we believe have the potential to transform the lives of patients who are living with rare and genetic diseases.
Sprache: Englisch
Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hyperoxaluria, and porphyria.
A Alnylam está liderando a tradução da Interferência de RNA (RNAi) em uma classe de medicamentos totalmente inovadora, que acreditamos ter o potencial de transformar a vida de pacientes acometidos por doenças genéticas e raras.
Max-Planck-Innovation ist verantwortlich für den Technologietransfer der Institute der Max-Planck-Gesellschaft, Deutschlands führender Forschungsorganisation für Grundlagenforschung.
Moderna hat sich zum Ziel gesetzt, die mit der mRNA-Forschung verbundenen Erwartungen an eine neue Generation von transformativen Medikamenten für Patienten zu erfüllen
Alnylam conduit la transformation de l'interférence ARN (ARNi) en une classe de médicaments innovante, totalement nouvelle qui, selon nous, a le potentiel de transformer la vie des patients atteints d'une maladie génétique rare.
Together we redefine healthcare by connecting the dots. Legal + strategy consulting for healthcare and life sciences.
Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
meta home desc
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
SAE Media Group is a highly professional, global company that specialises in the production of Business-to-Business Conferences, Workshops and Masterclasses. Part of the SAE Media Group, SMi researches, creates and delivers events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical sectors.
Pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart.
https://www.wavegenome.com
The page describes and summarises all technical aspects involved in quantitative gene expression analysis using real-time qPCR & qRT-PCR. It presents a lot of cyclers, kits, dyes, chemistries, and services involved. Companies and institutions can present their qPCR technologies, knowledge and services right here.
Database of research protocols in bioscience including molecular biology, cell biology, immunology, plant biology, developmental biology, neuroscience, bioinformatics, genetics, etc. Also hosts discipline-specific discussion forums and provides free PubMed alerting service
Horizon Discovery drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine. With more than a decade of experience in the engineering of cell lines, Horizon offers innovative tools and services based upon the ability to modulate,
The leading supplier of laboratory equipment, chemicals, and services used in scientific research, safety, healthcare, and education.
NEB is a leader in the discovery and development of molecular biology reagents. Restriction enzymes, polymerases, competent cells, sample prep for NGS, and more.
Prove it. We'll help. Our custom oligo synthesis platforms provide innovative research tools for genomics applications using NGS, CRISPR, qPCR, and synthetic biology
ISA Pharmaceuticals develops targeted, rationally designed immunotherapeutics for the treatment of cancer and persistent virus infections.
Das Gesundheitswesen und die Wissenschaft aus Bürger- und Patientensicht. Der Blog behandelt die Themen Interessenkonflikte, Transparenz, Patientenorganisationen, evidenzbasierte Medizin und Pharma.
Jazz Pharmaceuticals is focused on improving patients' lives by identifying, developing, and commercializing products that address unmet medical needs.
Eagle Pharmaceuticals is a specialty pharmaceutical company realizing the untapped potential of life-saving medicines. See what we're doing to bring brilliant science to life.
The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients.
Krka first joined the Irish market with prescription medicines in 2011. Since then we have developed a portfolio of over 100 formulations covering a large number of therapeutic areas including Cardiovascular, CNS, and Gastro Intestinal.
Wir wickeln den gesamten Herstellungs- und Verpackungsprozess Ihres Produktes ab. Auch ab Kleinmengen. Höchste Qualitätsstandards.
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.
Am Max-Planck-Institut für molekulare Genetik wird untersucht, wie die Funktion des Genoms reguliert und kontrolliert werden. Der Schwerpunkt liegt auf der Untersuchung von genregulatorischen Netzwerken und ihrer Rolle bei der Entwicklung des Organismus und bei der Entstehung von Krankheiten.
The mission of CELLSCRIPT is to provide the best technologies and products for translation of RNA in cells for clinical research and therapeutics.
Ivermectin for COVID-19: real-time analysis of all 248 studies
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Learn more about how Rhythm is changing how rare genetic diseases of obesity are diagnosed and treated.
Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation.
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
The Hereditary Disease Foundation is a non-profit research foundation which funds innovative genetic research towards curing Huntington's disease and other brain disorders. Since it's formation in 1968, the foundation has been responsible for several prolific scientific breakthroughs in brain diseases and genetic mapping.
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
Erfahre auf unserer Home-Seite mehr über das Tiroler Krebsforschungsinstitut, unsere Vision, Herausforderungen und Forschungsgruppen.